SCHEMBL8560277

SCHEMBL8560277

Clc1ccc2sc(Sc3cc[c]cc3)nc2c1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ PPARA Q07869 6/20 0.48
▸ ALOX5 P09917 3/20 0.44
▸ LOXL2 Q9Y4K0 1/20 0.44
▸ IDO1 P14902 1/20 0.44
▸ TMEM97 Q5BJF2 2/20 0.43
▸ CTRC Q99895 2/20 0.43
▸ GLB1 P16278 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8564013 0.82 SMN1; SMN2 (0.59) SMN1; SMN2NPSR1PPARAALOX5LOXL2
SCHEMBL8561692 0.78 HPGD (0.58) SMN1; SMN2NPSR1USP2LMNAMAPT
SCHEMBL8523609 0.77 SMN1; SMN2 (0.74) SMN1; SMN2NPSR1PPARAALOX5LOXL2
SCHEMBL1748171 0.74 SMN1; SMN2 (1.00) SMN1; SMN2NPSR1PPARAALOX5LOXL2
SCHEMBL30602946 0.74 SMN1; SMN2 (1.00) SMN1; SMN2NPSR1PPARAALOX5LOXL2
SCHEMBL12584997 0.73 SMN1; SMN2 (0.58) SMN1; SMN2NPSR1PPARAALOX5LOXL2
SCHEMBL11601529 0.72 SMN1; SMN2 (0.57) SMN1; SMN2NPSR1PPARAALOX5LOXL2
SCHEMBL9622398 0.72 SMN1; SMN2 (0.71) SMN1; SMN2NPSR1PPARAALOX5TMEM97
SCHEMBL31038096 0.72 FBP1 (0.74) SMN1; SMN2NPSR1MEN1LMNAMAPT
SCHEMBL30423143 0.72 SMN1; SMN2 (0.71) SMN1; SMN2NPSR1PPARAALOX5TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5814646-A TREATING THE PROGRESSION OF ALZHEIMER'S DISEASE, BRAIN DISORDERS ELI LILLY AND COMPANY (US) 1998-09-29 — — US disclosed
Send feedback